Zimmer Biomet Inc. (ZBH)
Zimmer Biomet Statistics
Share Statistics
Zimmer Biomet has 199.07M shares outstanding. The number of shares has increased by -4.65% in one year.
| Shares Outstanding | 199.07M |
| Shares Change (YoY) | -4.65% |
| Shares Change (QoQ) | -2.25% |
| Owned by Institutions (%) | 88.52% |
| Shares Floating | 198.75M |
| Failed to Deliver (FTD) Shares | 38 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.63M, so 3.83% of the outstanding shares have been sold short.
| Short Interest | 7.63M |
| Short % of Shares Out | 3.83% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 4.45 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is 12.94. Zimmer Biomet 's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | 12.94 |
| PS Ratio | 10.56 |
| Forward PS | 2.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zimmer Biomet Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | 112.40K |
| Profits Per Employee | 0 |
| Employee Count | 18.00K |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -19.17% in the last 52 weeks. The beta is 1.02, so Zimmer Biomet 's price volatility has been higher than the market average.
| Beta | 1.02 |
| 52-Week Price Change | -19.17% |
| 50-Day Moving Average | 106.3 |
| 200-Day Moving Average | 109.08 |
| Relative Strength Index (RSI) | 45.02 |
| Average Volume (20 Days) | 1.72M |
Income Statement
In the last 12 months, Zimmer Biomet had revenue of 2.02B and earned 0 in profits. Earnings per share was 0.
| Revenue | 2.02B |
| Gross Profit | 1.28B |
| Operating Income | 0 |
| Net Income | 0 |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 415.80M in cash and 6.00B in debt, giving a net cash position of -5.58B.
| Cash & Cash Equivalents | 415.80M |
| Total Debt | 6.00B |
| Net Cash | -5.58B |
| Retained Earnings | 10.38B |
| Total Assets | 21.37B |
| Working Capital | 3.08B |
Cash Flow
In the last 12 months, operating cash flow was 1.58B and capital expenditures -602.80M, giving a free cash flow of 1.20B.
| Operating Cash Flow | 1.58B |
| Capital Expenditures | -602.80M |
| Free Cash Flow | 1.20B |
| FCF Per Share | null |
Margins
Gross margin is 63.21%, with operating and profit margins of 0% and 0%.
| Gross Margin | 63.21% |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 59.51% |
Dividends & Yields
ZBH pays an annual dividend of $0.48, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | $0.48 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 10.84% |
| Earnings Yield | 0% |
| FCF Yield | 5.83% |
Analyst Forecast
The average price target for ZBH is $120, which is 15.7% higher than the current price. The consensus rating is "Hold".
| Price Target | $120 |
| Price Target Difference | 15.7% |
| Analyst Consensus | Hold |
| Analyst Count | 22 |
Stock Splits
The last stock split was on Mar 1, 2022. It was a forward split with a ratio of 103:100.
| Last Split Date | Mar 1, 2022 |
| Split Type | forward |
| Split Ratio | 103:100 |
Scores
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 6 |